Progress of Bevacizumab in Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

Progress of Bevacizumab in Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

Lung cancer is the most commonly diagnosed cancer worldwide. Malignant pleural effusion (MPE) caused by advanced lung cancer seriously affect the patients’ quality of life and prognosis. The management of MPE includes thoracentesis, pleurodesis, indwelling pleural catheters and drug perfusion in ple...

Full description

Bibliographic Details
Main Authors: Yujie LIU, Panwen TIAN
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2019-02-01
Series:Chinese Journal of Lung Cancer
Subjects:
Bevacizumab
Lung neoplasms
Malignant pleural effusion
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2019.02.07

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2019.02.07

Similar Items